|
| Status |
Public on Jul 28, 2020 |
| Title |
Prognostic Molecular Signatures and Biomarkers for Metastatic Progression in Stage I and II Clear Cell Renal Cell Carcinomas |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Expression profiling by RT-PCR
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
32850445 |
| |
| Submission date |
Jul 27, 2020 |
| Last update date |
Jun 12, 2023 |
| Contact name |
Andrew Shih |
| E-mail(s) |
ashih@northwell.edu
|
| Phone |
516-562-2960
|
| Organization name |
Feinstein Institute - Northwell Health
|
| Street address |
350 Community Dirive
|
| City |
Mahasset |
| State/province |
NY |
| ZIP/Postal code |
11030 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL18942 |
Applied Biosystems Taqman Low Density Array Human microRNA Card A+B Set v3.0 |
|
| Samples (86)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE143630 |
Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas |
| GSE155209 |
Prognostic Molecular Biomarkers for Metastatic Progression in Stage I and II Clear Cell Renal Cell Carcinomas |
|
| Relations |
| BioProject |
PRJNA648969 |
Less...
More...